Lymphotoxin and Lymphoid Neogenesis
Lymphotoxin and Lymphoid Neogenesis
批准号:
7998877
负责人:
Nancy H. Ruddle
金额:
$4.86万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-01-15 至 2010-03-31
关键词:
AcuteAutoimmunityB-LymphocytesCharacteristicsChronicDevelopmentFluorescenceGenesGoalsGrowthHigh Endothelial VenuleImmunizationInflammationInsulin-Dependent Diabetes MellitusLacZ GenesLigandsLymphangiogenesisLymphatic vesselLymphoidMagnetic Resonance ImagingMaintenanceMusOrganPNAdPhenotypeRecoveryRegulationRoleSignal TransductionStagingSystemTestingTetracyclinesTimeTumor Necrosis Factor ReceptorTumor Necrosis Factor-Betadensityinhibitor/antagonistmacrophagenovelsulfotransferase
中文摘要
描述(由申请人提供):该项目的目标是了解淋巴器官发育和功能的个体发育和炎症。定向过表达的光毒素(LT)(LTa或LTab)导致具有淋巴器官特征的异位淋巴聚集体。这些“三级淋巴器官”(TLO)也见于自身免疫性慢性炎症的许多情况,包括胰岛素依赖型糖尿病(IDDM)的早期阶段。高内皮微静脉(HEV)基因在发育、TLO和急性炎症中受到调节。成熟HEV表型的特征在于PNAd、LTbR和HEV硫转移酶(HEC-6ST)的表达,其取决于通过正常小鼠和HEC-6ST- lacZ小鼠中的LTbR的信号传导。在免疫后,HEV暂时回复到不成熟表型,然后恢复。恢复依赖于B细胞和LTbR。淋巴管生成也发生在TLO和急性炎症中。在免疫后早期,LV和HEV标志物均阳性的血管的出现依赖于LTbR。通过磁共振成像(MRI)和荧光显示淋巴管的新型双峰树枝状聚合物的结果表明,LT缺陷的小鼠具有缺陷的LV。LT如何促进淋巴管生成尚不清楚。将检验两个假设。假设一淋巴管在炎症和发育中受LT调节;假说II。通过LT的持续信号传导对于淋巴器官的维持和功能是必需的,特别是关于HEV和LV。具体目标是:1.通过确定B细胞是否产生调节HEV和LV的LT配体,通过评估巨噬细胞在淋巴管生成中的作用,以及通过确定双阳性血管是否代表从HEV出芽的LV,来确定HEV和LV在急性炎症中如何被调节; 2.通过评估血管表型、密度和功能、巨噬细胞的作用以及LTbR和TNFR信号传导,确定HEVs和LV在慢性炎症中是如何调节的; 3.通过评估LV功能和表型,确定LT是否以及如何影响组成型LV 4。通过LTbR和TNFR抑制剂治疗以及通过四环素诱导系统开启和关闭LT,确定是否需要持续的LT信号传导来维持TLO中的HEV和LV。阐明戊型肝炎病毒和左心室的调节将提供策略,抑制自身免疫,并允许控制胰岛炎。
英文摘要
DESCRIPTION (provided by applicant): The goal of this project is to understand lymphoid organ development and function in ontogeny and inflammation. Directed over expression of lymphotoxin (LT) (either LTa or LTab) results in ectopic lymphoid aggregates with the characteristics of lymphoid organs. These "tertiary lymphoid organs" (TLOs) are also seen in many situations of chronic inflammation in autoimmunity, including the early stages of insulin dependent diabetes mellitus (IDDM). High endothelial venule (HEV) genes are regulated in development, in TLOs, and in acute inflammation. The mature HEV phenotype, characterized by expression of PNAd, LTbR, and a HEV suIfotransferase (HEC-6ST) depends on signaling through the LTbR in normal and HEC6ST- lacZ mice. After immunization, HEVs revert transiently to an immature phenotype and then recover. The recovery is dependent on B cells and LTbR. Lymphangiogenesis also occurs in TLOs and in acute inflammation. At early times after immunization, the occurrence of vessels that are positive for both LV and HEV markers is dependent on LTbR. Results with a novel bimodal dendrimer that visualizes lymphatic vessels by magnetic resonance imaging (MRI) and fluorescence suggest that mice deficient in LT have defective LVs. It is not known how LT contributes to lymphangiogenesis. Two hypotheses will be tested. Hypothesis I. Lymphatic vessels are regulated by LT in inflammation and development; Hypothesis II. Continual signaling through LT is necessary for maintenance and function of lymphoid organs particularly in respect to HEVs and LVs. The specific aims are to: 1. Determine how HEVs and LVs are regulated in acute inflammation by determining if B cells produce the LT ligand that regulates HEVs and LVs, by evaluating the role of macrophages in lymphangiogenesis, and by determining if the double positive vessels represent LVs budding from HEVs; 2. Determine how HEVs and LVs are regulated in chronic inflammation by evaluating vessel phenotype, density, and function, the role of macrophages, and LTbR and TNFR signaling; 3. Determine if and how LT influences constitutive LVs by evaluating LV function and phenotype 4. Determine if continual LT signaling is necessary to maintain HEVs and LVs in TLOs by treatment with LTbR and TNFR inhibitors and by turning LT on and off with a tetracycline inducible system. Elucidation of HEV and LV regulation will provide strategies for their inhibition in autoimmunity and allow control of insulitis.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Lymphocyte traffic in lymphoid organ neogenesis: differential roles of Ltalpha and LTalphabeta.
淋巴器官新生中的淋巴细胞运输:Ltα 和 LTαβ 的不同作用。
DOI:
--
发表时间:
2002
期刊:
Advances in experimental medicine and biology
影响因子:
--
作者:
[Drayton,DanielleL, Chan,Kee, Lesslauer,Werner, Lee,Jason, Ying,XiaoYan, Ruddle,NancyH]
通讯作者:
Ruddle,NancyH
DOI:
10.1371/journal.pbio.1001672
发表时间:
2013-10
期刊:
PLoS biology
影响因子:
9.8
作者:
[Mionnet C, Mondor I, Jorquera A, Loosveld M, Maurizio J, Arcangeli ML, Ruddle NH, Nowak J, Aurrand-Lions M, Luche H, Bajénoff M]
通讯作者:
Bajénoff M
DOI:
10.4049/jimmunol.0804324
发表时间:
2009-08-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Ruddle NH, Akirav EM]
通讯作者:
Akirav EM
Ectopic LT alpha beta directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase.
异位LT Alphaββ指导淋巴器官新生成,并具有外周节点地址和HEV限制的磺胺转移酶的表达。
DOI:
10.1084/jem.20021761
发表时间:
2003-05-05
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
[Drayton DL, Ying X, Lee J, Lesslauer W, Ruddle NH]
通讯作者:
Ruddle NH
Lymphatic Vessel Imaging
-
批准号:8013023
-
项目类别:
-
资助金额:$20.69万
-
财政年份:2010
-
负责人:Nancy H. Ruddle
-
依托单位:
Lymphatic Vessel Imaging
-
批准号:7772428
-
项目类别:
-
资助金额:$24.83万
-
财政年份:2010
-
负责人:Nancy H. Ruddle
-
依托单位:
Neural-Immune Interacations: Pathology and Molecular Mechanisms of Repair
-
批准号:7540286
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2008
-
负责人:Nancy H. Ruddle
-
依托单位:
Lymphotoxin and Lymphoid Neogenesis
-
批准号:7898647
-
项目类别:
-
资助金额:$32.92万
-
财政年份:2000
-
负责人:Nancy H. Ruddle
-
依托单位:
LYMPHOTOXIN AND LYMPHOID NEOGENESIS
-
批准号:6517755
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2000
-
负责人:Nancy H. Ruddle
-
依托单位:
Lymphotoxin and Lymphoid Neogenesis
-
批准号:7478539
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2000
-
负责人:Nancy H. Ruddle
-
依托单位:
LYMPHOTOXIN AND LYMPHOID NEOGENESIS
-
批准号:6748471
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2000
-
负责人:Nancy H. Ruddle
-
依托单位:
Lymphotoxin and Lymphoid Neogenesis
-
批准号:7655268
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2000
-
负责人:Nancy H. Ruddle
-
依托单位:
Lymphotoxin and Lymphoid Neogenesis
-
批准号:7215306
-
项目类别:
-
资助金额:$8.24万
-
财政年份:2000
-
负责人:Nancy H. Ruddle
-
依托单位:
LYMPHOTOXIN AND LYMPHOID NEOGENESIS
-
批准号:6089911
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2000
-
负责人:Nancy H. Ruddle
-
依托单位:
LYMPHOTOXIN AND LYMPHOID NEOGENESIS
-
批准号:6381812
-
项目类别:
-
资助金额:$31.91万
-
财政年份:2000
-
负责人:Nancy H. Ruddle
-
依托单位:
LYMPHOTOXIN AND LYMPHOID NEOGENESIS
-
批准号:6635264
-
项目类别:
-
资助金额:$31.84万
-
财政年份:2000
-
负责人:Nancy H. Ruddle
-
依托单位:
Lymphotoxin and Lymphoid Neogenesis
-
批准号:7322589
-
项目类别:
-
资助金额:$33.83万
-
财政年份:2000
-
负责人:Nancy H. Ruddle
-
依托单位:
TERTIARY LYMPHOID ORGANS IN TYPE I DIABETES MELLITUS
-
批准号:6534132
-
项目类别:
-
资助金额:$25.45万
-
财政年份:1999
-
负责人:Nancy H. Ruddle
-
依托单位:
TERTIARY LYMPHOID ORGANS IN TYPE I DIABETES MELLITUS
-
批准号:6170931
-
项目类别:
-
资助金额:$28.1万
-
财政年份:1999
-
负责人:Nancy H. Ruddle
-
依托单位:
TERTIARY LYMPHOID ORGANS IN TYPE I DIABETES MELLITUS
-
批准号:2909178
-
项目类别:
-
资助金额:$26.8万
-
财政年份:1999
-
负责人:Nancy H. Ruddle
-
依托单位:
TERTIARY LYMPHOID ORGANS IN TYPE I DIABETES MELLITUS
-
批准号:6374042
-
项目类别:
-
资助金额:$27.72万
-
财政年份:1999
-
负责人:Nancy H. Ruddle
-
依托单位:
TERTIARY LYMPHOID ORGANS IN TYPE I DIABETES MELLITUS
-
批准号:6653815
-
项目类别:
-
资助金额:$29.41万
-
财政年份:1999
-
负责人:Nancy H. Ruddle
-
依托单位:
TUMOR NECROSIS FACTORS IN IDDM
-
批准号:2069518
-
项目类别:
-
资助金额:$7.57万
-
财政年份:1994
-
负责人:Nancy H. Ruddle
-
依托单位:
PUBLIC HEALTH TRAINEESHIPS
-
批准号:2056359
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1994
-
负责人:Nancy H. Ruddle
-
依托单位:
海外基金